Malignant melanoma risk after exposure to fertility drugs: Results from a large Danish cohort study

Cancer Causes and Control

Volumn 19, Issue 7, 2008, Pages 759-765

  Hannibal, Charlotte Gerd ^a   Jensen, Allan ^a   Sharif, Heidi ^a   Kjaer, Susanne Krüger ^a,b  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Clomiphene; Fertility drugs; Gonadotrophins; Infertility; Malignant melanoma

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; FERTILITY PROMOTING AGENT; GONADORELIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; DENMARK; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; COHORT STUDIES; DENMARK; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; MELANOMA; MIDDLE AGED; OVULATION INDUCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS;

EID: 48149100105     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9138-5     Document Type: Article

References (37)

1. Titus-Ernstoff L (2000) An overview of the epidemiology of cutaneous melanoma. Clin Plast Surg 27:305-316
2. National Board of Health (2007) The cancer registry 2007, Copenhagen
3. Green A, Trichopoulos D (2002) Skin cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. New York: Oxford University Press, Inc., pp 281-300
4. Neale RE, Darlington S, Murphy MF, Silcocks PB, Purdie DM, Talback M (2005) The effects of twins, parity and age at first birth on cancer risk in Swedish women. Twin Res Hum Genet 8:156-162
5. Wyshak G, Frisch RE, Albright NL, Albright TE, Schiff I (1989) Reproductive factors and melanoma of the skin among women. Int J Dermatol 28:527-530
6. Lambe M, Thorn M, Sparen P, Bergstrom R, Adami HO (1996) Malignant melanoma: reduced risk associated with early childbearing and multiparity. Melanoma Res 6:147-153
7. Karagas MR, Zens MS, Stukel TA et al (2006) Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 17:11-19
8. Holly EA, Weiss NS, Liff JM (1983) Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 70:827-831
9. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N (1996) Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 73:1126-1131
10. Beral V, Evans S, Shaw H, Milton G (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50:681-685
11. Beral V, Ramcharan S, Faris R (1977) Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 36:804-809
12. Fathalla MF (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2:163
13. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC (1985) Do regular ovulatory cycles increase breast cancer risk? Cancer 56:1206-1208
14. Sovino H, Sir-Petermann T, Devoto L (2002) Clomiphene citrate and ovulation induction. Reprod Biomed Online 4:303-310
15. Mosgaard B, Lidegaard O, Andersen AN (1995) Use of fertility drugs in Denmark 1973-1993. An analysis based on sale statistics. Acta Obstet Gynecol Scand 74:614-618
16. Ministry of the Interior and Health (2006) The Danish medicines agency 2006, Copenhagen
17. Wysowski DK (1993) Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril 60:1096-1098
18. Fuller PN (1999) Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature. Am J Obstet Gynecol 180:1499-1503
19. Kuppens E, Bergman W, Welvaart K, Bruijn JA, Scheffer E (1992) Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy. Melanoma Res 2:71-74
20. Brinton LA, Melton LJ III, Malkasian GD Jr, Bond A, Hoover R (1989) Cancer risk after evaluation for infertility. Am J Epidemiol 129:712-722
21. Modan B, Ron E, Lerner-Geva L et al (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147:1038-1042
22. Ron E, Lunenfeld B, Menczer J et al (1987) Cancer incidence in a cohort of infertile women. Am J Epidemiol 125:780-790
23. Venn A, Watson L, Lumley J, Giles G, King C, Healy D (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346:995-1000
24. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1995) Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Res 5:123-127
25. Holly EA, Cress RD, Ahn DK (1995) Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 141:943-950
26. Althuis MD, Scoccia B, Lamb EJ et al (2005) Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193:668-674
27. Young P, Purdie D, Jackman L, Molloy D, Green A (2001) A study of infertility treatment and melanoma. Melanoma Res 11:535-541
28. International Agency for Research on Cancer (2007) GLOBOCAN 2002, France
29. Jensen A, Sharif H, Svare EI, Frederiksen K, Kjaer SK (2007) Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev 16:1400-1407
30. Hannibal CG, Jensen A, Sharif H, Kjaer SK (2007) Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 23(2):451-456
31. National Board of Health (2007) The national patient registry 2007, Copenhagen
32. Danish Civil Registration System. (2007) The registry of civil registration 2007, Copenhagen
33. National Board of Health (2007) The medical birth registry 2007, Copenhagen
34. Prentice RL (1986) A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73:1-11
35. Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586-1590
36. Beral V (1983) Parity and susceptibility to cancer. Ciba Found Symp 96:182-203
37. Smith MA, Fine JA, Barnhill RL, Berwick M (1998) Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 27:751-757